TrialOpen Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton Syndrome
Trial details
- Registry ID
- NCT05789056
- Phase
- Phase 2, Phase 3
Drug research
QRX003, 4% Lotion
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton SyndromeNCT05789056 | Quoin Pharmaceuticals | Phase 2, Phase 3 | Recruiting | 2026-12-30Estimated |
| Clinical Study of QRX003 Lotion in Subjects With Netherton SyndromeNCT06953466 | Quoin Pharmaceuticals | Phase 2, Phase 3 | Recruiting | 2026-12-30Estimated |
Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome
Trial details
- Registry ID
- NCT06953466
- Phase
- Phase 2, Phase 3
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |